KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inovio Pharmaceuticals (INO) Gains from Equity Investments (2016 - 2018)

Inovio Pharmaceuticals (INO) has disclosed Gains from Equity Investments for 9 consecutive years, with -$228665.0 as the latest value for Q3 2018.

  • Quarterly Gains from Equity Investments rose 45.98% to -$228665.0 in Q3 2018 from the year-ago period, while the trailing twelve-month figure was -$228665.0 through Jun 2019, up 79.85% year-over-year, with the annual reading at -$360795.0 for FY2018, 55.28% up from the prior year.
  • Gains from Equity Investments hit -$228665.0 in Q3 2018 for Inovio Pharmaceuticals, up from -$259971.0 in the prior quarter.
  • In the past five years, Gains from Equity Investments ranged from a high of $505926.0 in Q1 2014 to a low of -$824390.0 in Q2 2014.
  • Historically, Gains from Equity Investments has averaged -$95835.4 across 5 years, with a median of -$2691.0 in 2016.
  • Biggest five-year swings in Gains from Equity Investments: skyrocketed 33263.41% in 2016 and later tumbled 15630.06% in 2017.
  • Year by year, Gains from Equity Investments stood at -$143659.0 in 2014, then soared by 302.09% to $290316.0 in 2015, then tumbled by 322.13% to -$644888.0 in 2016, then increased by 10.13% to -$579546.0 in 2017, then soared by 60.54% to -$228665.0 in 2018.
  • Business Quant data shows Gains from Equity Investments for INO at -$228665.0 in Q3 2018, -$259971.0 in Q2 2018, and $127841.0 in Q1 2018.